Drug
Gadolinium clinical trials
Also written Gd.
- studies test it
- 6
- open now
- 1
- in phase 3
- 0
- first study started
- 2006
Keep track of what changes. Save the Gadolinium studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 2
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
OHSU Knight Cancer Institute (3) · Massachusetts General Hospital (2) · University of Missouri-Columbia (1)
Often tested with
Tested in the same studies.
Ferrosoferric Oxide (3) · Injection Route of Administration (1) · Injectable Dosage Form (1)
Studies
Open first, then newest update. How each study uses Gadolinium is read from its arms, and is right about nine times in ten.
Testing it · 6
- Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous SystemRecruitingPhase 2OHSU Knight Cancer InstituteNCT03270059Written as Gadolinium
- Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain TumorsTerminatedPhase 2OHSU Knight Cancer InstituteNCT00659126Written as Gadolinium
- DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain TumorsCompletedEarly Phase 1OHSU Knight Cancer InstituteNCT00978562Written as Gadolinium
- A Feasibility Study to Assess the Use of Gadolinium in Computed TomographyWithdrawnPhase 4Massachusetts General HospitalNCT02163005Written as Gadolinium
- Use of Gadolinium in CT Pulmonary AngiographyWithdrawnPhase 4Massachusetts General HospitalNCT02234375Written as Gadolinium
- Dispersal Pattern for Spine Injections (Gadolinium Contrast)CompletedNot applicableUniversity of Missouri-ColumbiaNCT02217280Written as Injection with Gadolinium
Codes
What other systems call Gadolinium · ClinicalTrials.gg INT007537
- MeSH (NLM) D005682GadoliniumConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) AU0V1LM3JTGADOLINIUMConfirmed FDA, NLM, Wikidata
- RxNorm 1310171Confirmed FDA, Wikidata
- Wikidata Q1832gadoliniumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C39765GadoliniumOne source FDA
- DrugBank DB12091One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005682 | Gadolinium | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | AU0V1LM3JT | GADOLINIUM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1310171 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1832 | gadolinium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C39765 | Gadolinium | One source FDA |
| DrugBank | DB12091 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.